New drug candidate targets Hard-to-Treat cancers in early trial
NCT ID NCT05156866
First seen Jan 19, 2026 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This early-stage study tests a new drug, TORL-2-307-ADC, in people with advanced solid tumors, including gastric, pancreatic, and gastroesophageal junction cancers. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 163 participants will receive the drug to help guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, 46804, United States
-
Providence St. Jude Medical Center
Fullerton, California, 92835, United States
-
START San Antonio
San Antonio, Texas, 78229, United States
-
Seoul National University Bundang Hospital
Seoul, 13620, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Texas Oncology-Austin
Austin, Texas, 78705, United States
-
Texas Oncology-Dallas
Dallas, Texas, 75246, United States
-
Texas Oncology-Tyler
Tyler, Texas, 75702, United States
-
Torrance Memorial Medical
Torrance, California, 90505, United States
-
UCLA - JCCC Clinical Research Unit
Los Angeles, California, 90095, United States
-
Washington University School of Medicine-Siteman Cancer Center
St Louis, Missouri, 63310, United States
Conditions
Explore the condition pages connected to this study.